Stéphane Paillard
Covering European fundraising, first-time fund managers, and the founders behind the rounds. Previously built event and community products across the French tech ecosystem; now runs Sesamers and hosts the Sesame Summit.
Latest from Stéphane
569 articlesSumary raises $25M seed to take AI accounting across Europe
Sumary's USD 25M seed, led by Singular, funds a Benelux push and a London commercial hub for its AI platform that prepares monthly closes…
Ancep raises $8.5M to automate commercial insurance placement
Creandum leads an $8.5M round in London's Ancep, whose AI agents prepare submissions and chase insurers for brokers. It is the fifth broker automation…
Crowd Threat raises £1M to pay local contributors for threat intelligence
Newcastle's Crowd Threat has raised £1M from two Northern funds to grow a network of paid local contributors who report security incidents. The money…
Seva Money raises $5M seed for the receiving end of remittances
Seva Money raises a $5M seed co-led by Blockwall and Revent to give remittance recipients a wallet and card, live in India and Mexico.
SRTD Biotech raises €31.5M seed for cell-selective mRNA
SRTD Biotech raised an oversubscribed €31.5 million seed led by Mérieux Equity Partners to take its cell-selective mRNA therapies toward an IND filing.
Memora raises €1.7M to bring cemetery software across Europe
Copenhagen's Memora raised DKK 13 million, led by True Collective, to take cemetery software that grew out of hands-on grave care to cemeteries across…
Marble Imaging raises €6M to build a German satellite constellation
Cherry Ventures leads an additional €6M for Bremen's Marble Imaging, which now plans its first satellite for early 2027 and 30 satellites by 2030.
Onodrim Industries raises $300M Series A to buy defense suppliers
Amsterdam-based Onodrim raised $300M at a $1.3B valuation, nine months after its seed, to take controlling stakes in European defense and industrial suppliers.
T-Therapeutics raises $133M Series B for TCR bispecifics
Johnson & Johnson Innovation and Eli Lilly joined Sanofi Ventures on the T-Therapeutics register while both of its TCR bispecific programs are still preclinical.
Granit raises €5M to take billing work off French clinicians
Seedcamp led €3.5M of the Paris company's €5M first round, with Bpifrance adding €1.5M non-dilutive, to put AI agents on the billing work of…